The Kynurenine Pathway and Polycystic Ovary Syndrome: Inflammation as a Common Denominator
- PMID: 35620306
- PMCID: PMC9128055
- DOI: 10.1177/11786469221099214
The Kynurenine Pathway and Polycystic Ovary Syndrome: Inflammation as a Common Denominator
Abstract
Polycystic ovary syndrome (PCOS) is a complex metabolic disorder commonly seen in females of reproductive age. The pathophysiology of PCOS is multifactorial and includes dysfunction in ovarian steroidogenesis and folliculogenesis, impaired gonadotropin levels, insulin resistance, gut microbiota imbalance, genetic predisposition, and lifestyle preferences. Low-grade inflammatory conditions such as obesity and impaired glucose tolerance are common metabolic disturbances in women with PCOS. A growing body of literature suggests strong evidence rendering PCOS in close proximity with chronic inflammation as documented by high levels of serum white blood cells, C-reactive protein, and various proinflammatory cytokines seen in this condition. Inflammation seems to be the most common metabolic denominator between the kynurenine pathway and PCOS. The association of tryptophan and kynurenine pathway has already been well documented in mood disorders, neurodegenerative diseases, chronic pain conditions, and different inflammatory states. In this manuscript, we describe the influence of sex steroid hormones on different enzymes of the KP; inflammatory nature of PCOS and CRP as a marker of IDO/TDO activity; and the effects of altered gut flora in women with PCOS. This review provides a novel view of the available evidence of tryptophan and downstream metabolites in PCOS in the context of underlying inflammation.
Keywords: Polycystic ovary syndrome; inflammation; insulin resistance; kynurenine pathway; metabolic disturbance; obesity; tryptophan.
© The Author(s) 2022.
Conflict of interest statement
Declaration of Conflicting Interests: The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures


Similar articles
-
Chronic Low Grade Inflammation in Pathogenesis of PCOS.Int J Mol Sci. 2021 Apr 6;22(7):3789. doi: 10.3390/ijms22073789. Int J Mol Sci. 2021. PMID: 33917519 Free PMC article. Review.
-
Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics.BMJ Open. 2018 Oct 27;8(10):e021860. doi: 10.1136/bmjopen-2018-021860. BMJ Open. 2018. PMID: 30368447 Free PMC article.
-
Polycystic Ovary Syndrome.Obstet Gynecol. 2018 Aug;132(2):321-336. doi: 10.1097/AOG.0000000000002698. Obstet Gynecol. 2018. PMID: 29995717 Review.
-
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update.Arch Gynecol Obstet. 2021 Mar;303(3):631-643. doi: 10.1007/s00404-020-05951-2. Epub 2021 Jan 13. Arch Gynecol Obstet. 2021. PMID: 33439300
-
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.Nutr Res Rev. 2018 Dec;31(2):291-301. doi: 10.1017/S0954422418000136. Epub 2018 Jul 23. Nutr Res Rev. 2018. PMID: 30033891 Review.
Cited by
-
Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation.Biomolecules. 2024 Jul 28;14(8):918. doi: 10.3390/biom14080918. Biomolecules. 2024. PMID: 39199306 Free PMC article. Review.
-
The Tryptophan and Kynurenine Pathway Involved in the Development of Immune-Related Diseases.Int J Mol Sci. 2023 Mar 17;24(6):5742. doi: 10.3390/ijms24065742. Int J Mol Sci. 2023. PMID: 36982811 Free PMC article. Review.
-
The Role of Aromatic Amino Acids in Polycystic Ovary Syndrome through Patients' Blood Metabolic Profiling: A Systematic Review of the Past Five Years.J Proteome Res. 2025 May 2;24(5):2208-2221. doi: 10.1021/acs.jproteome.4c00937. Epub 2025 Apr 17. J Proteome Res. 2025. PMID: 40244806 Free PMC article.
-
Effect of hormone therapy on tryptophan metabolism and atherosclerosis among postmenopausal women.Climacteric. 2025 Jun 13:1-7. doi: 10.1080/13697137.2025.2509838. Online ahead of print. Climacteric. 2025. PMID: 40512395
-
Alteration of Branched-Chain and Aromatic Amino Acid Profile as a Novel Approach in Studying Polycystic Ovary Syndrome Pathogenesis.Nutrients. 2023 Sep 26;15(19):4153. doi: 10.3390/nu15194153. Nutrients. 2023. PMID: 37836437 Free PMC article.
References
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25. - PubMed
-
- Okoroh EM, Hooper WC, Atrash HK, Yusuf HR, Boulet SL. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008. Am J Obstet Gynecol. 2012;207:299.e1-299.e7. - PubMed
-
- Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31:2841-2855. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous